CVS vs ELV — Key Metrics
| Metric | CVS (CVS HEALTH CORP) | ELV (ELEVANCE HEALTH INC) |
|---|---|---|
| Price | 85.69 | 388.82 |
| Market Cap | 109.59 Billion | 84.32 Billion |
| P/E (TTM) | 22.32 | 17.17 |
| P/B (Quarterly) | 1.591 | 1.886 |
| P/S (TTM) | 0.26 | 0.42 |
| Net Profit Margin (TTM) | 1.2 | 2.5 |
| Gross Margin (TTM) | 14.2 | 15.1 |
| ROE (TTM) | 6.4 | 11.2 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
CVS · CVS HEALTH CORP
Outperform
ELV · ELEVANCE HEALTH INC
Outperform
Recommendation Summary
Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: ELV.
Financial Metrics
Prices delayed ~15 min
| CVS | Metrics | ELV |
|---|---|---|
| $85.69 | Price | $388.82 |
| — | Market Capitalization | — |
| 22.32 | Price to Earnings Ratio | 17.17 |
| 0.26 | Price to Sales | 0.42 |
| 9.32 | Price to FCF Ratio | 13.41 |
| 1.87 | Price to Gross Profit | 2.77 |
| 1.45 | Price to Current Assets | 1.26 |